Radiology

Singular Health Group is currently pursuing HITRUST certification to satisfy the stringent data privacy requirements often demanded by large-scale United States healthcare providers. This objective marks a definitive shift for the Australian med-tech firm as it moves beyond its research roots to

Targeting somatostatin receptor-positive tumors of the foregut, midgut, and hindgut, Bexlutry utilizes lutetium-177 to deliver localized radiation directly to malignant cells. This recent approval by the U.S. Food and Drug Administration (FDA) represents a significant shift for Curium as it

The necessity of general anesthesia for pediatric neuroimaging may soon decrease as acquisition times for diagnostic-grade scans drop below the 100-second mark. This advancement represents a significant shift in the landscape of diagnostic neuroimaging, where the integration of artificial

Targeted radiopharmaceutical therapies ensure that radioactive agents are delivered directly to malignant cells while minimizing collateral damage to healthy tissue. The appointment of Dr. Amir Iravani as the Director of the Theranostics Program and Vice Chair of Clinical Research at UCLA Health

Building on its existing enterprise-grade operating system, Aidoc’s new investigational tool integrates generative AI directly into the workflows used by medical professionals. This represents a fundamental shift in diagnostic radiology by moving beyond simple flagging of abnormalities toward

Recent clinical findings indicate that nearly half of patients with an initial negative scan undergo significant treatment modifications following a second imaging attempt. This discovery challenged the traditional reliance on a single diagnostic window, highlighting a critical blind spot in the